Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Suvaxyn PCV   
Auth. number : EU/2/09/099
INN : Porcine circovirus recombinant virus (cpcv) 1-2, inactivated
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI09 - Immunologicals for suidae
Pharmacological subgroup: QI09A - Pig
Chemical subgroup: QI09AA - Inactivated viral vaccines
Chemical substance: QI09AA07 - Porcine circovirus
(See WHO ATCvet Index)
Indication: Active immunisation of pigs over the age of 3 weeks against Porcine Circovirus type 2 (PCV2).
Marketing Authorisation Holder: Zoetis Belgium S.A.
Rue Laid Burniat 1, 1348 Louvain-La-Neuve, Belgique

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2009 Centralised - Authorisation EMEA/V/C/149 (2009)6045 of 24/07/2009
25/02/2010 Centralised - Variation EMEA/V/C/149/II/1
28/04/2010 Centralised - Variation EMEA/V/C/149/IA/2
01/10/2010 Centralised - Suspension of martketing authorisation EMEA/V/C/149/A-45/65 (2010)6747 of 27/09/2010
25/05/2011 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/149/T/4 (2011)3711 of 23/05/2011
23/07/2012 Centralised - Variation EMEA/V/C/149/IA/6
Updated with Decision(2012)7892 of 29/10/2012
12/10/2012 Centralised - Lift of suspension EMEA/V/C/149/Z/7 (2012)7205 of 10/10/2012
01/11/2012 Centralised - Variation (2012)7892 of 29/10/2012
22/05/2013 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/149/T/9 (2013)2987 of 16/05/2013
05/09/2013 Centralised - Variation EMEA/V/C/149/IA/12/G
Updated with Decision(2014)560 of 29/01/2014
10/10/2013 Centralised - Variation EMEA/V/C/149/II/11/G
Updated with Decision(2014)560 of 29/01/2014
31/01/2014 Centralised - Modification EMEA/V/C/149/Art.45/10 (2014)560 of 29/01/2014
11/06/2014 Centralised - Renewal EMEA/V/C/149/R/16 (2014)3946 of 06/06/2014